FDA Warns About Misleading Ads for Byetta, Cymbalta
The Food and Drug Administration today issued warning letters to the makers of the diabetes drug Byetta and the depression drug Cymbalta for what the agency says are false and misleading advertising practices.
Continue →Kidney Injury Risks Behind Label Change for Type 2 Diabetes Drug Byetta
Labeling on the type 2 diabetes drug Byetta has been changed to include the risk of kidney functioning problems, the Food and Drug Administration said.
Continue →FDA Orders Revisions to Januvia and Janumet Labeling for Acute Pancreatitis
The Food and Drug Administration is warning about dozens of cases of acute pancreatitis reported in people taking the Type 2 diabetes drugs Januvia and Janumet.
Continue →Pancreatic Disease Risk Increased by Type 2 Diabetes Drug Byetta
Byetta, a drug commonly prescribed for the treatment of type 2 (adult onset) diabetes, has been linked to an increased risk of deadly pancreatic disease. Dozens of Byetta patients have suffered a painful injury called hemorrhagic pancreatitis, or inflammation of the pancreas, that resulted in death or serious injuries. The Food and Drug Administration has issued several public advisories about Byetta’s connection to pancreatic disease and warned users about the risk.
Continue →
facebook
rss
twitter